These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis. Ehmann L; Zoller M; Minichmayr IK; Scharf C; Huisinga W; Zander J; Kloft C Int J Antimicrob Agents; 2019 Sep; 54(3):309-317. PubMed ID: 31229669 [TBL] [Abstract][Full Text] [Related]
8. Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients. Kaska M; Havel E; Selke-Krulichova I; Safranek P; Bezouska J; Martinkova J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):219-226. PubMed ID: 29582860 [TBL] [Abstract][Full Text] [Related]
9. Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure? Esteve-Pitarch E; Gumucio-Sanguino VD; Cobo-Sacristán S; Shaw E; Maisterra-Santos K; Sabater-Riera J; Pérez-Fernandez XL; Rigo-Bonnin R; Tubau-Quintano F; Carratalà J; Colom-Codina H; Padullés-Zamora A Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):527-538. PubMed ID: 34131869 [TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Patients: How to Achieve Best Dosage Regimen According to the Clinical Situation. O'Jeanson A; Larcher R; Le Souder C; Djebli N; Khier S Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):695-705. PubMed ID: 34403127 [TBL] [Abstract][Full Text] [Related]
11. Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study. Ehmann L; Zoller M; Minichmayr IK; Scharf C; Maier B; Schmitt MV; Hartung N; Huisinga W; Vogeser M; Frey L; Zander J; Kloft C Crit Care; 2017 Oct; 21(1):263. PubMed ID: 29058601 [TBL] [Abstract][Full Text] [Related]
12. Development of a dosing nomogram for continuous-infusion meropenem in critically ill patients based on a validated population pharmacokinetic model. Minichmayr IK; Roberts JA; Frey OR; Roehr AC; Kloft C; Brinkmann A J Antimicrob Chemother; 2018 May; 73(5):1330-1339. PubMed ID: 29425283 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of standard-dose meropenem in critically ill patients on continuous renal replacement therapy: a prospective observational trial. Onichimowski D; Będźkowska A; Ziółkowski H; Jaroszewski J; Borys M; Czuczwar M; Wiczling P Pharmacol Rep; 2020 Jun; 72(3):719-729. PubMed ID: 32301057 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and Pharmacodynamic Characteristics of Vancomycin and Meropenem in Critically Ill Patients Receiving Sustained Low-efficiency Dialysis. Oliveira MS; Machado AS; Mendes ET; Chaves L; Perdigão Neto LV; Vieira da Silva C; Cavani Jorge Santos SR; Sanches C; Macedo E; Levin AS Clin Ther; 2020 Apr; 42(4):625-633. PubMed ID: 32199609 [TBL] [Abstract][Full Text] [Related]
16. Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis. Pařízková RČ; Martínková J; Havel E; Šafránek P; Kaška M; Astapenko D; Bezouška J; Chládek J; Černý V Crit Care; 2021 Jul; 25(1):251. PubMed ID: 34274013 [TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetic Analysis of Meropenem in Critically Ill Patients With Acute Kidney Injury Treated With Continuous Hemodiafiltration. Niibe Y; Suzuki T; Yamazaki S; Suzuki T; Takahashi N; Hattori N; Nakada TA; Oda S; Ishii I Ther Drug Monit; 2020 Aug; 42(4):588-594. PubMed ID: 32049890 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures. Wong G; Briscoe S; McWhinney B; Ally M; Ungerer J; Lipman J; Roberts JA J Antimicrob Chemother; 2018 Nov; 73(11):3087-3094. PubMed ID: 30137377 [TBL] [Abstract][Full Text] [Related]
19. Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections. Burger R; Guidi M; Calpini V; Lamoth F; Decosterd L; Robatel C; Buclin T; Csajka C; Marchetti O J Antimicrob Chemother; 2018 Dec; 73(12):3413-3422. PubMed ID: 30304491 [TBL] [Abstract][Full Text] [Related]
20. Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used? Carlier M; Carrette S; Roberts JA; Stove V; Verstraete A; Hoste E; Depuydt P; Decruyenaere J; Lipman J; Wallis SC; De Waele JJ Crit Care; 2013 May; 17(3):R84. PubMed ID: 23642005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]